Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine

SIMPLE SUMMARY: The increasing number of data supporting use of a personalized approach in cancer treatment, is changing the path of patient’s management. In the same time, the availability of technologies should allow patients to receive the best test for the specific individual condition. This is...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Horgan, Denis, Ciliberto, Gennaro, Conte, Pierfranco, Curigliano, Giuseppe, Seijo, Luis, Montuenga, Luis M., Garassino, Marina, Penault-Llorca, Frederique, Galli, Fabrizia, Ray-Coquard, Isabelle, Querleu, Denis, Riegman, Peter, Kerr, Keith, Van Poppel, Hein, Bjartell, Anders, Codacci-Pisanelli, Giovanni, Koeva-Balabanova, Jasmina, Paradiso, Angelo, Maravic, Zorana, Fotaki, Vassiliki, Malats, Nuria, Bernini, Chiara, Buglioni, Simonetta, Kent, Alastair, Munzone, Elisabetta, Belina, Ivica, Van Meerbeeck, Jan, Duffy, Michael, Jagielska, Beata, Capoluongo, Ettore
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Guidelines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7867284/
https://ncbi.nlm.nih.gov/pubmed/33540773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13030583
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars